Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027
What it means
- What to watch: There is a hard number in this story (100%) — the interesting part is how it compares with the last few like it.
- How the stock is trading: $STLN -34.19% in the latest session.
- Timing: It dropped mid-session, while New York was open, so the move beside it may already include the market's first reaction.
Where the stock stands
$STLN last traded at $4.41, -34.19% on the session. That puts it 38% shy of its 52-week high of $7.13 and 90% clear of its low of $2.32 — a little below the middle of the range. Over the year it has ranged 207% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $STLN page.
How much coverage it is getting
This is the only story Wook has logged on $STLN in the last 30 days — a quiet name that just got a headline. 12 related stories — same name or same desk — are lined up beside this one if you want the whole thread.
The bigger picture
Earnings stories turn less on the headline numbers than on how they compare with what analysts expected, and on guidance for next quarter. A beat with weak guidance can land worse than a miss with a raised outlook — markets grade on the curve. On Wook's supply-chain scanner, Health Care reads watch today — early signs of strain worth keeping an eye on.
Coming up
$STLN earnings in 6 days. These were on the calendar before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company are almost here.
What to watch next
For the receipts, the $STLN page has the full chart, the filings and the valuation model these figures come from. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and run the numbers on request — how far $STLN is from its high, or how this week's coverage compares.
How this analysis was made
Seeking Alpha published it, and Wook filed it under Earnings. It reads bullish at medium severity because of “growth” in the wording, with nothing on the bearish side to offset it. It was matched to $STLN. It carried $650 million, $660 million, $4 million and $6 million, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Seeking Alpha published this on November 6, 2026. $STLN has moved -2.78% ($4.53 to $4.41). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.